Лечение артериальной гипертонии у пациентов с ортостатической артериальной гипотонией: научные данные и мнения экспертов

Статья посвящена проблеме лечения артериальной гипертонии (АГ) у пациентов с ортостатической артериальной гипотонией (ОАГ). В течение многих лет считалось, что лечение АГ может увеличивать риск развития ОАГ у лиц пожилого и старческого возраста. Однако появляется все больше источников доказательной информации, которые свидетельствуют о том, что более интенсивные режимы антигипертензивной терапии с достижением более низких целевых уровней артериального давления сопровождаются снижением риска развития ОАГ. В статье подробно обсуждаются такие источники. Приводятся данные о патофизиологических звеньях развития ОАГ, а также о подходах к ее диагностике в клинической практике. Рассматривается проблема выбора оптимальной антигипертензивной терапии у пациентов с ОАГ. Обсуждается проблема лечения АГ при наличии ОАГ у пожилых пациентов со старческой астенией. В статье представлены мнения экспертов по поводу тактики обследования и лечения пациентов с АГ и ОАГ, которые отражены в современных клинических рекомендациях.

1. Kulkarni S., Jenkins D., Dhar A., Mir F. Treating Lows: Management of Orthostatic Hypotension. J Cardiovasc Pharmacol. 2024;84(3):303—315. doi:10.1097/FJC.0000000000001597

2. Saedon N. I., Pin Tan M., Frith J. The Prevalence of Orthostatic Hypotension: A Systematic Review and Meta-Analysis. J Gerontol A Biol Sci Med Sci. 2020;75(1):117—122. doi: 10.1093/gerona/gly188.

3. Weiss A., Grossman E., Beloosesky Y., Grinblat J. Orthostatic hypotension in acute geriatric ward: is it a consistent finding? Arch Intern Med. 2002;162(20):2369—2374. doi: 10.1001/archinte.162.20.2369.

4. Farrell M. C., Shibao C.A. Morbidity and mortality in orthostatic hypotension. Auton Neurosci. 2020;229:102717. doi: 10.1016/j.autneu.2020.102717.

5. Brailsford B., East E. J., Clayton J., Sathyanarayanan A. Orthostatic Hypotension-An Approach to Work Up and Management. Br J Hosp Med (Lond). 2025;86(5):1-9. doi: 10.12968/hmed.2024.0602.

6. Shibao C., Grijalva C. G., Raj S. R., Biaggioni I., Griffin M. R. Orthostatic hypotension-related hospitalizations in the United States. Am J Med. 2007;120(11):975—980. doi: 10.1016/j.amjmed.2007.05.009.

7. Duggan E., Romero-Ortuno R., Kenny R. A. Admissions for orthostatic hypotension: an analysis of NHS England Hospital Episode Statistics data. BMJ Open. 2019;9(11):e034087. doi: 10.1136/bmjopen-2019-034087.

8. Schmanske N., Ngo J. M., Kalra K., Nanna M. G., Damluji A. A. Healthy ageing in older adults with cardiovascular disease. Eur Heart J. 2025;46(26):2536—2551. doi: 10.1093/eurheartj/ehaf231.

9. Freeman R., Wieling W., Axelrod F. B., Benditt D. G., Benarroch E., Biaggioni I., Cheshire W. P., Chelimsky T., Cortelli P., Gibbons C. H., Goldstein D. S., Hainsworth R., Hilz M. J., Jacob G., Kaufmann H., Jordan J., Lipsitz L. A., Levine B. D., Low P. A., Mathias C., Raj S. R., Robertson D., Sandroni P., Schatz I. J, Schondorf R., Stewart J. M., van Dijk J. G. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Auton Neurosci. 2011;161(1-2):46—48. doi: 10.1016/j.autneu.2011.02.004.

10. Mol A., Bui Hoang P. T. S., Sharmin S., Reijnierse E. M., van Wezel R. J. A., Meskers C. G. M., Maier A. B. Orthostatic Hypotension and Falls in Older Adults: A Systematic Review and Meta-analysis. J Am Med Dir Assoc. 2019;20(5):589—597.e5. doi: 10.1016/j.jamda.2018.11.003.

11. Hendriks S., Ranson J. M., Peetoom K., Lourida I., Tai X. Y., de Vugt M., Llewellyn D. J., Köhler S. Risk Factors for Young-Onset Dementia in the UK Biobank. JAMA Neurol. 2024;81(2):134—142. doi: 10.1001/jamaneurol.2023.4929.

12. Xin W., Lin Z., Mi S. Orthostatic hypotension and mortality risk: a meta-analysis of cohort studies. Heart. 2014;100(5):406—413. doi: 10.1136/heartjnl-2013-304121.

13. Satoh M., Ohkubo T., Miura K., Harada A., Tsutsui A., Hozawa A., Shimizu Y., Ishikawa S., Kokubo Y., Okamura T., Murakami Y.; Evidence for Cardiovascular Prevention from Observational Cohorts in Japan (EPOCH–JAPAN) Research Group. Long-term risk of cardiovascular mortality according to age group and blood pressure categories of the latest guideline. Hypertens Res. 2025;48(4):1428—1433. doi: 10.1038/s41440-025-02151-w.

14. Ou Y. N., Tan C. C., Shen X. N., Xu W., Hou X. H., Dong Q., Tan L., Yu J. T. Blood Pressure and Risks of Cognitive Impairment and Dementia: A Systematic Review and Meta-Analysis of 209 Prospective Studies. Hypertension. 2020;76(1):217—225. doi: 10.1161/HYPERTENSIONAHA.120.14993.

15. Min M., Shi T., Sun C., Liang M., Zhang Y., Wu Y., Sun Y. The association between orthostatic hypotension and dementia: A meta-analysis of prospective cohort studies. Int J Geriatr Psychiatry. 2018;33(12):1541—1547. doi: 10.1002/gps.4964.

16. Dani M., Taraborrelli P., Panagopoulos D., Dirksen A., Torocastro M., Sutton R., Lim P. B. New horizons in the ageing autonomic nervous system: orthostatic hypotension and supine hypertension. Age Ageing. 2022;51(8):afac150. doi: 10.1093/ageing/afac150.

17. Tinetti M. E., Han L., McAvay G. J., Lee D. S., Peduzzi P., Dodson J. A., Gross C. P., Zhou B., Lin H. Anti-hypertensive medications and cardiovascular events in older adults with multiple chronic conditions. PLoS One. 2014;9(3):e90733. doi: 10.1371/journal.pone.0090733.

18. Kaye M. G., Rutowski J., Aftab H., Pandey R., Khan R., Kalot M.A., Anand R., Graham S. P. Screening for orthostatic hypotension in the geriatric population in a real-world primary care setting reduces prescribed antihypertensive medications. Blood Press Monit. 2023 Dec 1;28(6):338—342. doi: 10.1097/MBP.0000000000000673.

19. Juraschek S. P., Hu J. R., Cluett J. L., Ishak A., Mita C., Lipsitz L.A., Appel L. J., Beckett N. S., Coleman R. L., Cushman W. C., Davis B. R., Grandits G., Holman R. R., Miller E. R. 3rd, Peters R., Staessen J. A., Taylor A. A., Thijs L., Wright J. T. Jr, Mukamal K. J. Effects of Intensive Blood Pressure Treatment on Orthostatic Hypotension : A Systematic Review and Individual Participant-based Meta-analysis. Ann Intern Med. 2021;174(1):58—68. doi: 10.7326/M20-4298.

20. Benarroch E. E. Physiology and Pathophysiology of the Autonomic Nervous System. Continuum (Minneap Minn). 2020;26(1):12—24. doi: 10.1212/CON.0000000000000817.

21. Diedrich A., Biaggioni I. Segmental orthostatic fluid shifts. Clin Auton Res. 2004 Jun;14(3):146—147. doi: 10.1007/s10286-004-0188-9.

22. Wieling W., van Dijk N., Thijs R. D., de Lange F. J., Krediet C. T., Halliwill J. R. Physical countermeasures to increase orthostatic tolerance. J Intern Med. 2015;277(1):69—82. doi: 10.1111/joim.12249.

23. Barone Gibbs B., Muldoon M. F., Conroy M. B., Paley J. L., Shimbo D., Perera S. Influence of Recent Standing, Moving, or Sitting on Daytime Ambulatory Blood Pressure. J Am Heart Assoc. 2023;12(17):e029999. doi: 10.1161/JAHA.123.029999.

24. Monahan K. D. Effect of aging on baroreflex function in humans. Am J Physiol Regul Integr Comp Physiol. 2007;293(1):R3—R12. doi: 10.1152/ajpregu.00031.2007.

25. Tomiyama H., Matsumoto C., Kimura K., Odaira M., Shiina K., Yamashina A. Pathophysiological contribution of vascular function to baroreflex regulation in hypertension. Circ J. 2014;78(6):1414—1419. doi: 10.1253/circj.cj-14-0064.

26. Ormezzano O., Cracowski J. L., Quesada J. L., Pierre H., Mallion J. M., Baguet J. P. EVAluation of the prognostic value of BARoreflex sensitivity in hypertensive patients: the EVABAR study. J Hypertens. 2008;26(7):1373—1378. doi: 10.1097/HJH.0b013e3283015e5a.

27. McDonald C., Pearce M. S., Wincenciak J., Kerr S. R., Newton J. L. Ambulatory Blood Pressure Variability Increases Over a 10-Year Follow-Up in Community-Dwelling Older People. Am J Hypertens. 2016;29(5):560—567. doi: 10.1093/ajh/hpv150.

28. Lee Y. K., Mazzucco S., Rothwell P. M., Payne S. J., Webb A. J. S. Blood Pressure Complexity Discriminates Pathological Beat-to-Beat Variability as a Marker of Vascular Aging. J Am Heart Assoc. 2022;11(3):e022865. doi: 10.1161/JAHA.121.022865.

29. Gallo G., Volpe M., Savoia C. Endothelial Dysfunction in Hypertension: Current Concepts and Clinical Implications. Front Med (Lausanne). 2022;8:798958. doi: 10.3389/fmed.2021.798958.

30. Gilani A., Ramsay S. E., Juraschek S. P., Papacosta O., Lennon L. T., Whincup P. H., Wannamethee S.G. Associations of the systolic and diastolic components of orthostatic hypotension with markers of cardiovascular risk in older men: A cross-sectional analysis from The British Regional Heart Study. J Clin Hypertens (Greenwich). 2020;22(10):1892—1901. doi: 10.1111/jch.13996.

31. Johansson M., Ricci F., Aung N., Sutton R., Melander O., Fedorowski A. Proteomic Profiling for Cardiovascular Biomarker Discovery in Orthostatic Hypotension. Hypertension. 2018;71(3):465—472. doi: 10.1161/HYPERTENSIONAHA.117.10365.

32. Grosu C., Noea O., Maștaleru A., Ignat E. B., Leon M. M. Neurogenic Orthostatic Hypotension in Parkinson Disease-A Narrative Review of Diagnosis and Management. J Clin Med. 2025;14(2):630. doi: 10.3390/jcm14020630.

33. Isik A. T., Dost F. S., Yavuz I., Ontan M. S., Ates Bulut E., Kaya D. Orthostatic hypotension in dementia with Lewy bodies: a meta-analysis of prospective studies. Clin Auton Res. 2023;33(2):133]—141. doi: 10.1007/s10286-023-00933-1.

34. Fleg J. L., Evans G. W., Margolis K. L., Barzilay J., Basile J. N., Bigger J. T., Cutler J. A., Grimm R., Pedley C., Peterson K., Pop-Busui R., Sperl-Hillen J., Cushman W. C. Orthostatic Hypotension in the ACCORD (Action to Control Cardiovascular Risk in Diabetes) Blood Pressure Trial: Prevalence, Incidence, and Prognostic Significance. Hypertension. 2016;68(4):888—895. doi: 10.1161/HYPERTENSIONAHA.116.07474.

35. Curcio F., Chiappetti R., De Furio M., Flocco V., Della Morte D., Testa G., Gargiulo G., Cacciatore F., Abete P., Galizia G.; European Union - NextGenerationEU - AGE-It Spoke 3. Chronic kidney disease and orthostatic hypotension in hospitalised older adults. Blood Press. 2024;33(1):2336243. doi: 10.1080/08037051.2024.2336243.

36. McNicholas T., Tobin K., O'Callaghan S., Kenny R. A. Is orthostatic hypotension more common in individuals with atrial fibrillation?-Findings from The Irish Longitudinal Study on Ageing (TILDA). Age Ageing. 2017;46(6):1006—1010. doi: 10.1093/ageing/afx096.

37. Soloveva A., Fedorova D., Villevalde S., Zvartau N., Mareev Y., Sitnikova M., Shlyakhto E., Fudim M. Addressing Orthostatic Hypotension in Heart Failure: Pathophysiology, Clinical Implications and Perspectives. J Cardiovasc Transl Res. 2020;13(4):549—569. doi: 10.1007/s12265-020-10044-1.

38. Rodriguez J., Blaber A. P., Kneihsl M., Trozic I., Ruedl R., Green D. A., Broadbent J., Xu D., Rössler A., Hinghofer-Szalkay H., Fazekas F., Goswami N. Poststroke alterations in heart rate variability during orthostatic challenge. Medicine (Baltimore). 2017;96(14):e5989. doi: 10.1097/MD.0000000000005989.

39. Bhanu C., Nimmons D., Petersen I., Orlu M., Davis D., Hussain H., Magammanage S., Walters K. Drug-induced orthostatic hypotension: A systematic review and meta-analysis of randomised controlled trials. PLoS Med. 2021;18(11):e1003821. doi: 10.1371/journal.pmed.1003821.

40. Gannon J., Claffey P., Laird E., Newman L., Kenny R. A., Briggs R. The cross-sectional association between diabetes and orthostatic hypotension in community-dwelling older people. Diabet Med. 2020;37(8):1299—1307. doi: 10.1111/dme.14187.

41. Wu J. S., Yang Y. C., Lu F. H., Wu C. H., Wang R. H., Chang C. J. Population-based study on the prevalence and risk factors of orthostatic hypotension in subjects with pre-diabetes and diabetes. Diabetes Care. 2009;32(1):69—74. doi: 10.2337/dc08-1389.

42. Jia G., Sowers J. R. Hypertension in Diabetes: An Update of Basic Mechanisms and Clinical Disease. Hypertension. 2021;78(5):1197—1205. doi: 10.1161/HYPERTENSIONAHA.121.17981.

43. Gibbons C. H., Schmidt P., Biaggioni I., Frazier-Mills C., Freeman R., Isaacson S., Karabin B., Kuritzky L., Lew M., Low P., Mehdirad A., Raj S.R., Vernino S., Kaufmann H. The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension. J Neurol. 2017;264(8):1567—1582. doi: 10.1007/s00415-016-8375-x.

44. Budyono C., Setiati S., Purnamasari D., Rumende C. M. The Proportion of Orthostatic Hypotension and Its Relationship with HbA1c Levels in Elderly Patients with Diabetes. Acta Med Indones. 2016;48(2):122—1228.

45. Lounici A., Beghdadi F., Tabti E., Benmekki A., Bestaoui M. H. Évaluation de la fréquence et des facteurs associés à l’hypotension orthostatique chez les diabétiques de type 2 [Evaluation of orthostatic hypotension frequency and associated factors in type 2 diabetics]. Ann Cardiol Angeiol (Paris). 2019;68(4):255—259. French. doi: 10.1016/j.ancard.2019.07.004.

46. Beretta M. V., Milan V. B., Hoffmeister M. C., Rodrigues T. C. Orthostatic hypotension, falls and in-hospital mortality among elderly patients with and without type 2 diabetes. J Hypertens. 2023 Mar 1;41(3):388-392. doi: 10.1097/HJH.0000000000003338.

47. Xiong Q., Li F., Chi H., Yang Y., Li M., Liu Y., Zhang Y., Leng B., Qi X., Sun H., Li Z., Zhang J. Orthostatic Hypotension Promotes the Progression From Mild Cognitive Impairment to Dementia in Type 2 Diabetes Mellitus. J Clin Endocrinol Metab. 2024 May 17;109(6):1454-1463. doi: 10.1210/clinem/dgad764.

48. Kaufmann H. Consensus statement on the definition of orthostatic hypotension, pure autonomic failure and multiple system atrophy. Clin Auton Res. 1996;6(2):125—126. doi: 10.1007/BF02291236.

49. Wieling W., Kaufmann H., Claydon V. E., van Wijnen V. K., Harms M. P. M., Juraschek S. P., Thijs R. D. Diagnosis and treatment of orthostatic hypotension. Lancet Neurol. 2022;21(8):735—746. doi: 10.1016/S1474-4422(22)00169-7.

50. Juraschek S. P., Miller E. R. 3rd, Appel L. J. Orthostatic Hypotension and Symptoms in the AASK Trial. Am J Hypertens. 2018;31(6):665—671. doi: 10.1093/ajh/hpy010.

51. Juraschek S. P., Cortez M. M., Flack J. M., Ghazi L., Kenny R. A., Rahman M., Spikes T., Shibao C. A., Biaggioni I.; American Heart Association Council on Hypertension. Orthostatic Hypotension in Adults With Hypertension: A Scientific Statement From the American Heart Association. Hypertension. 2024;81(3):e16—e30. doi: 10.1161/HYP.0000000000000236.

52. Rizzo M., Pansini A., Colucci M., Boccalone E., Mone P. Frailty in nursing home residents. Eur J Intern Med. 2023;115:152—153. doi: 10.1016/j.ejim.2023.05.027.

53. Richter D., Guasti L., Walker D., Lambrinou E., Lionis C., Abreu A., Savelieva I., Fumagalli S., Bo M., Rocca B., Jensen M. T., Pierard L., Sudano I., Aboyans V., Asteggiano R. Frailty in cardiology: definition, assessment and clinical implications for general cardiology. A consensus document of the Council for Cardiology Practice (CCP), Association for Acute Cardio Vascular Care (ACVC), Association of Cardiovascular Nursing and Allied Professions (ACNAP), European Association of Preventive Cardiology (EAPC), European Heart Rhythm Association (EHRA), Council on Valvular Heart Diseases (VHD), Council on Hypertension (CHT), Council of Cardio-Oncology (CCO), Working Group (WG) Aorta and Peripheral Vascular Diseases, WG e-Cardiology, WG Thrombosis, of the European Society of Cardiology, European Primary Care Cardiology Society (EPCCS). Eur J Prev Cardiol. 2022;29(1):216—227. doi: 10.1093/eurjpc/zwaa167.

54. Choi J. Y., Ryu D. R., Lee H. Y., Lee J. H., Hong Y., Park S. K., Lee J. H., Hwang S. J., Kim K. H., Lee S. H., Kim S. Y., Park J. H., Kim S. H., Kim H. L., Choi J. H., Kim C. H., Cho M. C., Kim K. I. Association Between Orthostatic Hypertension and Frailty Among Older Patients With Hypertension. Hypertension. 2024;81(6):1383—1390. doi: 10.1161/HYPERTENSIONAHA.123.22382.

55. Benetos A., Petrovic M., Strandberg T. Hypertension Management in Older and Frail Older Patients. Circ Res. 2019;124(7):1045-1060. doi: 10.1161/CIRCRESAHA.118.313236.

56. Duval G. T., Raud E., Gohier H., Dramé M., Tabue-Teguo M., Annweiler C. Orthostatic hypotension and cognitive impairment: Systematic review and meta-analysis of longitudinal studies. Maturitas. 2024l;185:107866. doi: 10.1016/j.maturitas.2023.107866.

57. Mol A., Reijnierse E. M., Bui Hoang P. T. S., van Wezel R. J. A., Meskers C. G. M., Maier A. B. Orthostatic hypotension and physical functioning in older adults: A systematic review and meta-analysis. Ageing Res Rev. 2018;48:122—144. doi: 10.1016/j.arr.2018.10.007.

58. Yamamoto K. Current issues in frailty and hypertension management. Hypertens Res. 2023;46(8):1917—1922. doi: 10.1038/s41440-023-01310-1.

59. Toba A., Ishikawa J. Current topics of frailty in association with hypertension and other medical conditions. Hypertens Res. 2023;46(5):1188—1194. doi: 10.1038/s41440-023-01200-6.

60. Mehta T., McClure L. A., White C. L., Taylor A., Benavente O. R., Lakshminarayan K. Effect of Postural Hypotension on Recurrent Stroke: Secondary Prevention of Small Subcortical Strokes (SPS3) Study. J Stroke Cerebrovasc Dis. 2019;28(8):2124—2131. doi: 10.1016/j.jstrokecerebrovasdis.2019.04.009.

61. ACCORD Study Group; Cushman W. C., Evans G. W., Byington R. P., Goff D.C. Jr, Grimm R. H. Jr, Cutler J. A., Simons-Morton D. G., Basile J. N., Corson M. A., Probstfield J. L., Katz L., Peterson K. A., Friedewald W. T., Buse J. B., Bigger J. T., Gerstein H. C., Ismail-Beigi F. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010;362(17):1575—1585. doi: 10.1056/NEJMoa1001286.

62. Pei J., Zhang H., Li Y., Yan J., Zheng K., Wang X., Zheng X. L., Hu X. Relationship between orthostatic blood pressure changes and intensive blood pressure management in patients with hypertension. Heart. 2022;109(2):111—118. doi: 10.1136/heartjnl-2022-321276.

63. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ. 1998 Sep 12;317(7160):703—713. https://doi.org/10.1136/bmj.317.7160.703

64. Beckett N. S., Peters R., Fletcher A. E., Staessen J. A., Liu L., Dumitrascu D., Stoyanovsky V., Antikainen R. L., Nikitin Y., Anderson C., Belhani A., Forette F., Rajkumar C., Thijs L., Banya W., Bulpitt C. J.; HYVET Study Group. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008;358(18):1887—1898. doi: 10.1056/NEJMoa0801369.

65. Staessen J. A., Fagard R., Thijs L., Celis H., Arabidze G. G., Birkenhäger W. H., Bulpitt C. J., de Leeuw P. W., Dollery C. T., Fletcher A. E., Forette F., Leonetti G., Nachev C., O'Brien E. T., Rosenfeld J., Rodicio J. L., Tuomilehto J., Zanchetti A. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet. 1997;350(9080):757—764. doi: 10.1016/s0140-6736(97)05381-6.

66. Neaton J. D., Grimm R. H. Jr, Prineas R. J., Stamler J., Grandits G. A., Elmer P. J., Cutler J. A., Flack J. M., Schoenberger J. A., McDonald R., et al. Treatment of Mild Hypertension Study. Final results. Treatment of Mild Hypertension Study Research Group. JAMA. 1993;270(6):713—724.

67. Juraschek S. P., Hu J. R., Cluett J. L., Ishak A. M., Mita C., Lipsitz L. A., Appel L. J., Beckett N. S., Coleman R. L., Cushman W. C., Davis B. R., Grandits G., Holman R. R., Miller E. R. 3rd, Peters R., Staessen J. A., Taylor A. A., Thijs L., Wright J. T. Jr, Mukamal K. J. Orthostatic Hypotension, Hypertension Treatment, and Cardiovascular Disease: An Individual Participant Meta-Analysis. JAMA. 2023;330(15):1459—1471. doi: 10.1001/jama.2023.18497.

68. Albasri A., Hattle M., Koshiaris C., Dunnigan A., Paxton B., Fox S. E., Smith M., Archer L., Levis B., Payne R. A., Riley R. D., Roberts N., Snell K. I. E., Lay-Flurrie S., Usher-Smith J., Stevens R., Hobbs F. D. R., McManus R. J., Sheppard J. P.; STRATIFY investigators. Association between antihypertensive treatment and adverse events: systematic review and meta-analysis. BMJ. 202;372:n189. doi: 10.1136/bmj.n189.

69. Ylitalo A., Airaksinen K. E., Sellin L., Huikuri H. V. Effects of combination antihypertensive therapy on baroreflex sensitivity and heart rate variability in systemic hypertension. Am J Cardiol. 1999;83(6):885—889. doi: 10.1016/s0002-9149(98)01067-4.

70. Ichikawa M., Suzuki H., Kumagai K., Ryuzaki M., Kumagai H., Nishizawa M., Saruta T. Baroreceptor function is restored by antihypertensive therapy through lowering of blood pressure in adult SHR. Clin Exp Pharmacol Physiol Suppl. 1995;22(1):S67—S69. doi: 10.1111/j.1440-1681.1995.tb02973.x.

71. Rivasi G., Rafanelli M., Mossello E., Brignole M., Ungar A. Drug-Related Orthostatic Hypotension: Beyond Anti-Hypertensive Medications. Drugs Aging. 2020;37(10):725—738. doi: 10.1007/s40266-020-00796-5.

72. Poon I. O., Braun U. High prevalence of orthostatic hypotension and its correlation with potentially causative medications among elderly veterans. J Clin Pharm Ther. 2005 Apr;30(2):173—178. doi: 10.1111/j.1365-2710.2005.00629.x.

73. Fedorowski A., Burri P., Juul-Möller S., Melander O. A dedicated investigation unit improves management of syncopal attacks (Syncope Study of Unselected Population in Malmo--SYSTEMA I). Europace. 2010;12(9):1322—1328. doi: 10.1093/europace/euq168.

74. Zia A., Kamaruzzaman S. B., Myint P. K., Tan M. P. The association of antihypertensives with postural blood pressure and falls among seniors residing in the community: a case-control study. Eur J Clin Invest. 2015;45(10):1069—1076. doi: 10.1111/eci.12508.

75. Sica D. A., Carter B., Cushman W., Hamm L. Thiazide and loop diuretics. J Clin Hypertens (Greenwich). 2011;13(9):639—643. doi: 10.1111/j.1751-7176.2011.00512.x.

76. Rapoport R. M., Soleimani M. Mechanism of Thiazide Diuretic Arterial Pressure Reduction: The Search Continues. Front Pharmacol. 2019;10:815. doi: 10.3389/fphar.2019.00815.

77. Dixon D. D., Muldowney J .A. S. 3rd. Management of neurogenic orthostatic hypotension in the heart failure patient. Auton Neurosci. 2020;227:102691. doi: 10.1016/j.autneu.2020.102691.

78. Kamaruzzaman S., Watt H., Carson C., Ebrahim S. The association between orthostatic hypotension and medication use in the British Women's Heart and Health Study. Age Ageing. 2010 Jan;39(1):51-6. doi: 10.1093/ageing/afp192. Epub 2009 Nov 6. PMID: 19897539.

79. Juraschek S. P., Cluett J. L., Belanger M. J., Anderson T. S., Ishak A., Sahni S., Millar C., Appel L. J., Miller E. R., Lipsitz L. A., Mukamal K. J. Effects of Antihypertensive Deprescribing Strategies on Blood Pressure, Adverse Events, and Orthostatic Symptoms in Older Adults: Results From TONE. Am J Hypertens. 2022;35(4):337—346. doi: 10.1093/ajh/hpab171.

80. Moonen J. E., Foster-Dingley J. C., de Ruijter W., van der Grond J., de Craen A. J., van der Mast R.C. Effect of discontinuation of antihypertensive medication on orthostatic hypotension in older persons with mild cognitive impairment: the DANTE Study Leiden. Age Ageing. 2016;45(2):249—255. doi: 10.1093/ageing/afv199.

81. Warwick J., Falaschetti E., Rockwood K., Mitnitski A., Thijs L., Beckett N., Bulpitt C., Peters R. No evidence that frailty modifies the positive impact of antihypertensive treatment in very elderly people: an investigation of the impact of frailty upon treatment effect in the HYpertension in the Very Elderly Trial (HYVET) study, a double-blind, placebo-controlled study of antihypertensives in people with hypertension aged 80 and over. BMC Med. 2015;13:78. doi: 10.1186/s12916-015-0328-1.

82. Wang Z., Du X., Hua C., Li W., Zhang H., Liu X., Wang Y., Jiang C., Guo J., Lv Qю, Anderson C. S., Dong J, Ma C. The Effect of Frailty on the Efficacy and Safety of Intensive Blood Pressure Control: A Post Hoc Analysis of the SPRINT Trial. Circulation. 2023;148(7):565—574. doi: 10.1161/CIRCULATIONAHA.123.064003.

83. O'Donoghue P., O'Halloran A. M., Kenny R. A., Romero-Ortuno R. Do the frail experience more adverse events from intensive blood pressure control? A 2-year prospective study in the Irish Longitudinal Study on Ageing (TILDA). EClinicalMedicine. 2022;45:101304. doi: 10.1016/j.eclinm.2022.101304.

84. Weijs R. W. J., de Roos B. M., Thijssen D. H. J., Claassen J. A. H. R. Intensive antihypertensive treatment does not lower cerebral blood flow or cause orthostatic hypotension in frail older adults. Geroscience. 2024;46(5):4635—4646. doi: 10.1007/s11357-024-01174-4. .

85. Klop M., Maier A. B., Meskers C. G. M., Steiner J. M., Helsloot D. O., van Wezel R. J. A., Claassen J. A. H. R., de Heus R. A. A. The effect of a change in antihypertensive treatment on orthostatic hypotension in older adults: A systematic review and meta-analysis. Exp Gerontol. 2024;193:112461. doi: 10.1016/j.exger.2024.112461.

86. Mancia G., Kreutz R., Brunström M., Burnier M., Grassi G., Januszewicz A., Muiesan M. L., Tsioufis K., Agabiti-Rosei E., Algharably E. A. E., Azizi M., Benetos A., Borghi C., Hitij J. B., Cifkova R, Coca A, Cornelissen V, Cruickshank J. K., Cunha P. G., Danser A. H. J., Pinho R. M., Delles C., Dominiczak A. F., Dorobantu M., Doumas M., Fernández-Alfonso M. S., Halimi J. M., Járai Z., Jelaković B., Jordan J., Kuznetsova T., Laurent S., Lovic D., Lurbe E., Mahfoud F.., Manolis A., Miglinas M., Narkiewicz K., Niiranen T., Palatini P., Parati G., Pathak A., Persu A., Polonia J., Redon J., Sarafidis P., Schmieder R., Spronck B., Stabouli S., Stergiou G., Taddei S., Thomopoulos C., Tomaszewski M., Van de Borne P., Wanner C., Weber T., Williams B., Zhang Z. Y., Kjeldsen S. E.. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens. 2023 Dec 1;41(12):1874-2071. doi: 10.1097/HJH.0000000000003480.

87. Unger T., Borghi C., Charchar F., Khan N. A., Poulter N. R., Prabhakaran D., Ramirez A., Schlaich M., Stergiou G. S., Tomaszewski M., Wainford R. D., Williams B., Schutte A. E. 2020 International Society of Hypertension global hypertension practice guidelines. J Hypertens. 2020;38(6):982—1004. doi: 10.1097/HJH.0000000000002453.

88. McEvoy J. W., McCarthy C. P., Bruno R. M., Brouwers S., Canavan M. D., Ceconi C., Christodorescu R. M., Daskalopoulou S. S., Ferro C. J., Gerdts E., Hanssen H., Harris J., Lauder L., McManus R. J., Molloy G. J., Rahimi K., Regitz-Zagrosek V., Rossi G. P., Sandset E. C., Scheenaerts B., Staessen J. A., Uchmanowicz I., Volterrani M., Touyz R. M.; ESC Scientific Document Group. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. Eur Heart J. 2024 Oct 7;45(38):3912—4018. doi: 10.1093/eurheartj/ehae178. Erratum in: Eur Heart J. 2025 Apr 7;46(14):1300. doi: 10.1093/eurheartj/ehaf031.

89. Whelton P. K., Carey R. M., Aronow W. S., Casey D. E. Jr, Collins K. J., Dennison Himmelfarb C., DePalma S. M., Gidding S., Jamerson K. A., Jones D. W., MacLaughlin E. J., Muntner P., Ovbiagele B., Smith S. C. Jr, Spencer C. C., Stafford R. S., Taler S. J., Thomas R. J., Williams K. A. Sr, Williamson J. D., Wright J. T. Jr. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71(6):1269—1324. doi: 10.1161/HYP.0000000000000066. Erratum in: Hypertension. 2018 Jun;71(6):e136—e139. doi: 10.1161/HYP.0000000000000075. Erratum in: Hypertension. 2018;72(3):e33. doi: 10.1161/HYP.0000000000000080.

90. Jones D. W., Ferdinand K. C., Taler S. J., Johnson H. M., Shimbo D., Abdalla M., Altieri M. M., Bansal N., Bello N. A., Bress A. P., Carter J., Cohen J. B., Collins K. J., Commodore-Mensah Y., Davis L. L., Egan B., Khan S. S., Lloyd-Jones D. M., Melnyk B. M., Mistry E. A., Ogunniyi M. O., Schott S. L., Smith S. C. Jr, Talbot A. W., Vongpatanasin W., Watson K. E., Whelton P. K., Williamson J. D. 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Hypertension. 2025 Aug 14. doi: 10.1161/HYP.0000000000000249. Epub ahead of print.

91. Hypertension in adults: diagnosis and management. London: National Institute for Health and Care Excellence (NICE); 2023 Nov 21. (NICE Guideline, No. 136.) Available from: www.ncbi.nlm.nih.gov/books/NBK547161/pdf/Bookshelf_NBK547161.pdf

92. NHG-Standaard Cardiovasculair risicomanagement (M84) Versie 4.1, september 2024. Availavle at: https://richtlijnen.nhg.org/standaarden/cardiovasculair-risicomanagement.

93. Wiersinga J., Jansen S., Peters M. J. L., Rhodius-Meester H. F. M., Trappenburg M. C., Claassen J. A. H. R., Muller M. Hypertension and orthostatic hypotension in the elderly: a challenging balance. Lancet Reg Health Eur. 2024;48:101154. doi: 10.1016/j.lanepe.2024.101154.

94. Min M., Shi T., Sun C., Liang M., Zhang Y., Bo G., Sun Y.. Orthostatic hypotension and the risk of atrial fibrillation and other cardiovascular diseases: An updated meta-analysis of prospective cohort studies. J Clin Hypertens (Greenwich). 2019;21(8):1221-1227. doi: 10.1111/jch.13613.

95. Shibao C. A., Juraschek S. P., Biaggioni I. 41 - Autonomic Dysfunction and Orthostatic Hypotension. In Bakris G.L., Sorrentino M.J., Laffin L.J. (eds.) Hypertension (pp. 466—475). 4th edn. Elsevier: Amsterdam, Netherlands. 2024.

96. Parsaik A. K., Singh B., Altayar O., Mascarenhas S. S., Singh S. K., Erwin P. J., Murad M. H. Midodrine for orthostatic hypotension: a systematic review and meta-analysis of clinical trials. J Gen Intern Med. 2013;28(11):1496—503. doi: 10.1007/s11606-013-2520-3.

97. Wieling W., Raj S. R., Thijs R. D. Are small observational studies sufficient evidence for a recommendation of head-up sleeping in all patients with debilitating orthostatic hypotension? MacLean and Allen revisited after 70 years. Clin Auton Res. 2009;19(1):8—12. doi:10.1007/s10286-009-0522-3

98. Fan C. W., Walsh C., Cunningham C. J. The effect of sleeping with the head of the bed elevated six inches on elderly patients with orthostatic hypotension: an open randomised controlled trial. Age Ageing. 2011;40(2):187—192. doi:10.1093/ageing/afq176.

99. Muller M., Smulders Y. M., de Leeuw P. W., Stehouwer C. D. Treatment of hypertension in the oldest old: a critical role for frailty? Hypertension. 2014;63(3):433—441. doi: 10.1161/HYPERTENSIONAHA.113.00911.

100. Materson B. J., Garcia-Estrada M., Preston R. A. Hypertension in the frail elderly. J Am Soc Hypertens. 2016;10(6):536—541. doi: 10.1016/j.jash.2016.03.187.

101. Guasti L., Ambrosetti M., Ferrari M., Marino F., Ferrini M., Sudano I., Tanda M. L., Parrini I., Asteggiano R., Cosentino M. Management of Hypertension in the Elderly and Frail Patient. Drugs Aging. 2022;39(10):763—772. doi: 10.1007/s40266-022-00966-7.

102. Nijskens C., Henstra M., Rhodius-Meester H., Yasar S., van Poelgeest E., Peters M., Muller M. Cardiovascular Risk Management in Persons with Dementia. J Alzheimers Dis. 2023;93(3):879—889. doi: 10.3233/JAD-230019.

103. Finucane C., O'Connell M. D., Donoghue O., Richardson K., Savva G. M., Kenny R. A. Impaired Orthostatic Blood Pressure Recovery Is Associated with Unexplained and Injurious Falls. J Am Geriatr Soc. 2017;65(3):474—482. doi: 10.1111/jgs.14563.

104. Hohtari-Kivimäki U., Salminen M., Vahlberg T., Kivelä S. L. Orthostatic Hypotension is a Risk Factor for Falls Among Older Adults: 3-Year Follow-Up. J Am Med Dir Assoc. 2021;22(11):2325—2330. doi: 10.1016/j.jamda.2021.07.010.

105. Johnson R., Turner K., Feder G., Cramer H. Shared decision making in consultations for hypertension: Qualitative study in general practice. Health Expect. 2021;24(3):917—929. doi: 10.1111/hex.13234.

106. Alharthi A., Liu X., Chen Y., Kruahong S., Commodore-Mensah Y., Himmelfarb C. R. Sociodemographic and Clinical Characteristics and Self-Care Behaviors Are Associated With Shared Decision-Making in Adults With Hypertension. J Am Heart Assoc. 2025 Jul 28:e036328. doi: 10.1161/JAHA.124.036328.

107. Collier D. J., Taylor M., Godec T., Shiel J., James R., Chowdury Y., Ebano P., Monk V., Patel M., Pheby J., Pheby R., Foubister A., David C., Saxena M., Richardson L., Siddle J., Timlin G., Goldsmith P., Deeming N., Poulter N. R., Gabe R., McManus R. J., Caulfield M. J. Personalized Antihypertensive Treatment Optimization With Smartphone-Enabled Remote Precision Dosing of Amlodipine During the COVID-19 Pandemic (PERSONAL-CovidBP Trial). J Am Heart Assoc. 2024;13(4):e030749. doi: 10.1161/JAHA.123.030749

108. Divisón-Garrote J. A., Ruilope L. M., de la Sierra A., de la Cruz J. J., Vinyoles E., Gorostidi M., Escobar-Cervantes C., Velilla-Zancada S. M., Segura J., Banegas J. R. Magnitude of Hypotension Based on Office and Ambulatory Blood Pressure Monitoring: Results From a Cohort of 5066 Treated Hypertensive Patients Aged 80 Years and Older. J Am Med Dir Assoc. 2017;18(5):452.e1—452.e6. doi: 10.1016/j.jamda.2017.01.015.

109. Kleipool E. E. F., Rozendaal E. S., Mahadew S. K. N., Kramer M. H. H., van den Born B. H., Serné E. H., Peters M. J. L., Muller M. The value of ambulatory blood pressure measurement to detect masked diastolic hypotension in older patients treated for hypertension. Age Ageing. 2021;50(4):1229—1235. doi: 10.1093/ageing/afaa287.

110. Кобалава Ж. Д., Конради А. О., Недогода С. В. и др. Артериальная гипертензия у взрослых. Клинические рекомендации 2024 // Российский кардиологический журнал. – 2024. – Т. 29, № 9. – С. 6117.